Clinical Trials Sponsored by Laura Johnston

Total 1925 results

Johnson & Johnson Pharmaceutical Research & Development...

Completed

An Efficacy and Safety Study of Topiramate in the Treatment of Alcohol Dependence

Alcoholism
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study To Evaluate The Effect Of Topiramate On Clinical And Electrophysiological Parameters In Subjects With Diabetic Peripheral Polyneuropathy

Diabetes Mellitus, Type 2 | Diabetic Neuropathies | Polyneuropathies
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures

Epilepsy | Seizures | Epilepsies, Partial
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A 52 Week Open-label Extension Trial Following the Double-blind Efficacy and Safety Study R076477-SCH-305.

Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Safety and Efficacy of Topiramate in the Treatment of Obese, Type 2 Diabetes Patients on a Controlled Diet

Obesity | Diabetes Mellitus, Type 2 | Diabetes Mellitus, Adult-Onset
Johnson & Johnson Pharmaceutical Research & Development...

Completed

Trial Evaluating Three Fixed Doses of Paliperidone Extended-Release (ER) Tablets and Olanzapine in the Treatment of Patients With Schizophrenia

Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Efficacy and Safety of Topiramate in the Treatment fo Obese, Type 2 Diabetic Patients Treated With Metformin

Obesity | Diabetes Mellitus, Type 2 | Diabetes Mellitus, Adult-Onset
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of Paliperidone Enantiomer Disposition With Different Formulations and the Bioavailability of Immediate- and Extended-release Paliperidone

Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development...

Completed

Safety and Efficacy of an Anti-Psychotic in Patients With Schizophrenia

Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development...

Completed

Gemcitabine With or Without Tipifarnib (R115777) in Treating Patients With Advanced Pancreatic Cancer

Pancreatic Neoplasms
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study to Assess the Safety, Dose Conversion, and Dose Individualization of Duragesic® (Fentanyl Transdermal Patch) in the Treatment of Children With Chronic Pain Requiring Narcotic Pain Relief Therapy

Chronic Pain
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Bioequivalence of 12 mg Paliperidone Extended Release Tablets Manufactured at Gurabo and Vacaville

Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development...

Completed

Epoetin Alfa for the Treatment of Anemia Resulting From Chronic Lymphocytic Leukemia

Neoplasms | Quality of Life | Cancer | Anemia | Leukemia, Lymphocytic | Leukemia, Lymphocytic, Chronic
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Safety and Effectiveness of a Flexible Dose of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's Disease

Dementia | Alzheimer Disease
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Safety and Effectiveness of Two Doses of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's Disease

Dementia | Alzheimer Disease
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study to Determine Whether Epoetin Alfa Can Reduce the Need for Blood Transfusions in Patients During the Period of Time Around Major Orthopedic Surgery.

Anemia | Blood Transfusion | Orthopedic Procedures
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Safety and Effectiveness of Two Doses of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's Disease

Dementia | Alzheimer Disease
Johnson & Johnson Pharmaceutical Research & Development...

Completed

The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving Chemotherapy

Lymphoma | Breast Cancer | Multiple Myeloma | Anemia | Ovarian Cancer | Prostate Cancer | Neoplasm | Esophagus Cancer | Carcinoma, Small Cell Lung
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Cardiac Safety Study of Galantamine in the Treatment of Alzheimer's Disease.

Alzheimer's Disease
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study to Determine the Safety of Epoetin Alfa and Whether Epoetin Alfa Can Reduce the Need for Blood Transfusions in Patients After Major Orthopedic Surgery.

Anemia | Blood Transfusion | Orthopedic Procedures
Johnson & Johnson Pharmaceutical Research & Development...

Completed

The Effect of Epoetin Alfa on the Anemia of Patients With Multiple Myeloma

Multiple Myeloma | Anemia
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa Versus Placebo in Facilitating the Presurgical Collection of Blood to be Used for Self-donation During Surgery on the Spine, Hip, or Knee.

Anemia | Orthopedic Procedures | Blood Transfusions, Autologous
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study to Determine the Safety and Effectiveness of Epoetin Alfa in Facilitating Self-donation of Blood Before Surgery in Patients Who Are Not Anemic and Who Will be Undergoing Orthopedic or Heart and Blood Vessel Surgery

Blood Transfusion | Orthopedic Surgery | Orthopedic Procedures | Cardiovascular Surgical Procedure | Blood Transfusion, Autologous
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Phase 2 Study of Farnesyl Transferase Inhibitor (R115777, Tipifarnib) in Patients With Refractory or Relapsed Acute Myeloid Leukemia.

Leukemia, Nonlymphocytic, Acute
Johnson & Johnson Pharmaceutical Research & Development...

Terminated

An Efficacy and Safety Study of Cisapride in Patients With Chronic Gastroparesis After Failure of Other Treatment Options

Gastroparesis
Johnson & Johnson Pharmaceutical Research & Development...

Terminated

A Study of Cisapride in Premature Infants With Feeding Problems

Infant, Premature | Infant, Newborn
Johnson & Johnson Pharmaceutical Research & Development...

Terminated

A Study of Cisapride in Patients With Symptomatic Gastro-Oesophageal Reflux Disease

Gastroesophageal Reflux
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder

Bipolar Disorder | Manic Episode
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic Episodes Associated With Bipolar I Disorder

Bipolar Disorders | Manic Episode
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study to Assess Safety and Tolerabiltiy Associated With a Switch From Oral Antipsychotic Medications to Long-acting Injectable Risperidone in Patients With Schizophrenia.

Psychotic Disorders | Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Safety and Efficacy of Long-term Correction of Anemia With Epoetin Alfa in Early Hemodialysis Patients

Anemia | Kidney Failure, Chronic
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study to Evaluate the Impact of Maintaining Hemoglobin Levels Using Epoetin Alfa in Patients With Metastatic Breast Cancer Receiving Chemotherapy

Quality of Life | Breast Neoplasms | Anemia
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of Long-acting Injectable Risperidone in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder

Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A First-in-Human Study of JNJ-28431754 in Healthy Male Volunteers

Healthy
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Clinical Study to Investigate the Effect on Pain Relief of a Single Dose of JNJ-39439335 in Patients With Chronic Osteoarthritis Pain of the Knee

Osteoarthritis, Knee
Johnson & Johnson Pharmaceutical Research & Development...

Completed

Intramuscular Injections of Paliperidone Palmitate in the Arm or Buttock of Subjects With Schizophrenia

Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of Paliperidone Blood Concentrations in Patients With Schizophrenia After Administration of Paliperidone Palmitate

Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study to Evaluate Pharmacokinetics, Safety and Tolerability After a Single Dose Administration of JNJ-31001074 in Pediatric Patients (12-17 Years) With Attention Deficit Hyperactivity Disorder (ADHD)

Attention Deficit Hyperactivity Disorder | Attention Deficit Disorders With Hyperactivity
Johnson & Johnson Pharmaceutical Research & Development...

Terminated

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Doses of JNJ-38431055 in Volunteers With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2
Danderyd Hospital
Johnson & Johnson Consumer Products Company Division of Johnson & Johnson...

Active, not recruiting

Periprosthetic Bone Remodeling Around Uncemented Components in Total Hip Arthroplasty (PeriBRUSBRAC)

Osteoarthritis

Sweden
Marie-laure Welter

Completed

Pallidal Stimulation in Patients With Post-anoxic and Idiopathic Dystonia

Dystonia

France
Johnson & Johnson International (Singapore) Pte...

Completed

A Study of High Risk Localized Prostate Cancer Participants Treated With Radical Prostatectomy and Perioperative Hormonal Therapy (ACE)

High Risk Localized Prostate Cancer

Japan, Korea, Republic of, Taiwan
University Hospital, Ghent
Johnson & Johnson; Medtronic

Completed

Autologous Platelet Enriched Gel Versus Metalloproteinase Inhibitor in the Healing of Chronic Lower Leg Ulcers

Chronic Lower Leg Ulcer

Belgium
M.D. Anderson Cancer Center
Johnson & Johnson

Completed

Phase I/II Evaluation of Temozolomide and ZARNESTRA (R115777) for Recurrent and Progressive Glioblastoma Multiforme

Glioblastoma Multiforme

United States
Seoul National University Hospital
Johnson & Johnson

Completed

Paliperidone ER(Invega®) on Depressive Symptoms of Schizophrenia Patients

Schizophrenia

Korea, Republic of
Johnson & Johnson Pharmaceutical Research & Development...

Approved for marketing

Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer

Urogenital Neoplasms | Genital Neoplasms, Male | Prostate Neoplasms | Genital Diseases, Male

United States, Australia, Hong Kong, Spain, Colombia, Mexico, Poland, Malaysia, Romania, Canada, Greece, Taiwan, Korea, Republic of, New Zealand, Singapore, Brazil, Russian Federation, Czech Republic, Puerto Rico, Thailand, Hungary and more
Johnson & Johnson Pharmaceutical Research & Development...

Completed

An Efficacy and Safety Study of Prucalopride in Participants With Chronic Constipation (Resolor)

Constipation

China, Taiwan, Australia, Korea, Republic of, Thailand
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study to Evaluate the Effect of Food on Levofloxacin Pharmacokinetics From an Oral Solution Formulation

Healthy
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study to Evaluate the Bioequivalence of an Oral Suspension Formulation, an Oral Solution Formulation, and the Marketed Tablet Formulation of Levofloxacin in Healthy Subjects

Healthy
Aarhus University Hospital Skejby
Johnson & Johnson

Completed

Nordic Bifurcation Study. How to Use Drug Eluting Stents (DES) in Bifurcation Lesions? (BIFI)

Coronary Artery Disease

Denmark

3

Subscribe